Phase I dose-escalating study of docetaxel in combination with 5-day continuous infusion of 5-fluorouracil in patients with advanced gastric cancer

被引：0
|
作者：
Se Hoon Park
Soo-Mee Bang
Eun Kyung Cho
Dong Bok Shin
Jae Hoon Lee
Woon KI Lee
Min Chung
机构：
[1] Gachon Medical School Gil Medical Center,Division of Hematology and Oncology, Department of Internal Medicine
[2] Gachon Medical School Gil Medical Center,Department of General Surgery
来源：
BMC Cancer | / 5卷
关键词：
Gastric Cancer; Docetaxel; Dose Level; Febrile Neutropenia; Dose Escalation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Phase I dose-escalating study of 24-h continuous infusion of 5-fluorouracil in combination with weekly docetaxel and cisplatin in patients with advanced gastric cancer
    Biyun Wang
    Wen Zhang
    Xiaonan Hong
    Ye Guo
    Jin Li
    Cancer Chemotherapy and Pharmacology, 2009, 63 : 213 - 218
  • [2] Phase I dose-escalating study of 24-h continuous infusion of 5-fluorouracil in combination with weekly docetaxel and cisplatin in patients with advanced gastric cancer
    Wang, Biyun
    Zhang, Wen
    Hong, Xiaonan
    Guo, Ye
    Li, Jin
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 63 (02) : 213 - 218
  • [3] A phase I trial of docetaxel and 5-day continuous infusion of 5-fluorouracil in patients with advanced or recurrent breast cancer
    Ando, M
    Watanabe, T
    Sasaki, Y
    Ying, DF
    Omuro, Y
    Katsumata, N
    Narabayashi, M
    Tokue, Y
    Fujii, H
    Igarashi, T
    Wakita, H
    Ohtsu, T
    Itoh, K
    Adachi, I
    Taguchi, T
    BRITISH JOURNAL OF CANCER, 1998, 77 (11) : 1937 - 1943
  • [4] COMBINATION CHEMOTHERAPY WITH CISPLATIN AND 5-FLUOROURACIL 5-DAY INFUSION IN THE THERAPY OF ADVANCED GASTRIC-CANCER - A PHASE-II TRIAL
    LACAVE, AJ
    BARON, FJ
    ANTON, LM
    ESTRADA, E
    DESANDE, LMG
    PALACIO, I
    ESTEBAN, E
    GRACIA, JM
    BUESA, JM
    FERNANDEZ, OA
    BARON, MG
    ANNALS OF ONCOLOGY, 1991, 2 (10) : 751 - 754
  • [5] Phase I dose-escalation study of docetaxel, nedaplatin, and 5-fluorouracil combination chemotherapy in patients with advanced esophageal cancer
    Miyazaki, Tatsuya
    Sohda, Makoto
    Tanaka, Naritaka
    Suzuki, Shigemasa
    Ieta, Keisuke
    Sakai, Makoto
    Sano, Akihiko
    Yokobori, Takehiko
    Inose, Takanori
    Nakajima, Masanobu
    Fukuchi, Minoru
    Ojima, Hitoshi
    Kato, Hiroyuki
    Kuwano, Hiroyuki
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (04) : 853 - 857
  • [6] Phase I dose-escalation study of docetaxel, nedaplatin, and 5-fluorouracil combination chemotherapy in patients with advanced esophageal cancer
    Tatsuya Miyazaki
    Makoto Sohda
    Naritaka Tanaka
    Shigemasa Suzuki
    Keisuke Ieta
    Makoto Sakai
    Akihiko Sano
    Takehiko Yokobori
    Takanori Inose
    Masanobu Nakajima
    Minoru Fukuchi
    Hitoshi Ojima
    Hiroyuki Kato
    Hiroyuki Kuwano
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 853 - 857
  • [7] Phase I/II study of docetaxel, cisplatin, and 5-fluorouracil combination chemoradiotherapy in patients with advanced esophageal cancer
    Miyazaki, Tatsuya
    Sohda, Makoto
    Tanaka, Naritaka
    Suzuki, Shigemasa
    Ieta, Keisuke
    Sakai, Makoto
    Sano, Akihiko
    Yokobori, Takehiko
    Inose, Takanori
    Nakajima, Masanobu
    Fukuchi, Minoru
    Ojima, Hitoshi
    Kato, Hiroyuki
    Kuwano, Hiroyuki
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 75 (03) : 449 - 455
  • [8] Phase I/II study of docetaxel, cisplatin, and 5-fluorouracil combination chemoradiotherapy in patients with advanced esophageal cancer
    Tatsuya Miyazaki
    Makoto Sohda
    Naritaka Tanaka
    Shigemasa Suzuki
    Keisuke Ieta
    Makoto Sakai
    Akihiko Sano
    Takehiko Yokobori
    Takanori Inose
    Masanobu Nakajima
    Minoru Fukuchi
    Hitoshi Ojima
    Hiroyuki Kato
    Hiroyuki Kuwano
    Cancer Chemotherapy and Pharmacology, 2015, 75 : 449 - 455
  • [9] Phase I evaluation of continuous 5-fluorouracil infusion followed by weekly paclitaxel in patients with advanced or recurrent gastric cancer
    Kondo, K
    Kobayashi, M
    Kojima, H
    Hirabayashi, N
    Kataoka, M
    Araki, K
    Matsui, T
    Takiyama, W
    Miyashita, Y
    Nakazato, H
    Nakao, A
    Sakamoto, J
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2005, 35 (06) : 332 - 337
  • [10] A phase I study of docetaxel and 5-fluorouracil in patients with advanced solid malignancies
    Petit, T
    Aylesworth, C
    Burris, H
    Ravdin, P
    Rodriguez, G
    Smith, L
    Peacock, N
    Smetzer, L
    Bellet, R
    Von Hoff, DD
    Rowinsky, EK
    ANNALS OF ONCOLOGY, 1999, 10 (02) : 223 - 229
12345